New Year's Resolutions & Alzheimer's Prevention
Common New Year’s Resolutions Not Only Important for your Waistline, But for your Mind Too
Attention: Assignment Editor, Food/Beverage Editor, Health/Medical Editor, Lifestyle Editor, News Editor
TORONTO/ONTARIO/MEDIA RELEASE--(Marketwire - Jan. 1, 2008) - New Year's resolutions for healthy eating and increased activity are now more important than ever, say Alzheimer's experts. Your mind needs it too.
Research has shown that a good diet, in particular the Mediterranean diet high in monounsaturated "healthy" fats, and regular physical activity, are also important to keep Alzheimer's at bay.
Mental activities such as crossword puzzles are also helpful to prevent onset of dementias such as Alzheimer's disease.
"In addition to these lifestyle changes, there is really exciting research in the pipelines to be hopeful about in the future," says Dr. Nathan Herrmann, geriatric researcher and psychiatrist at Sunnybrook Health Sciences Centre. "We're involved in new and exciting trials that are investigating not only new medications to stop or slow down the accumulation of amyloid, but also new immunotherapy approaches through vaccines to help prevent or slow down the progression of the disease."
Amyloid is a sticky toxic protein that gradually deposits between nerve cells in the brain in Alzheimer's disease, damaging and killing cells. "It is important to stop this abnormal buildup," says Dr. Herrmann, also a Professor at University of Toronto. "It's possible these new approaches will become available within the next five to ten years."
January is Alzheimer's awareness month. An estimated 420,000 Canadians over 65 years have Alzheimer's disease or a related dementia. Alzheimer's is a progressive degenerative disease for which there is no preventive medicine or cure. It is characterized by a decline in mental abilities and changes in personality and behaviour. Usually there is a loss of functioning that eventually impedes the ability to carry out everyday activities. Alzheimer's disease is under-diagnosed and under-treated in Canada and worldwide.
Symptoms of Alzheimer's include: progressive loss of memory, difficulty with concentration, decrease in problem-solving skills and judgment, confusion and delusions, altered perception, impaired recognition, impaired skilled motor function, disorientation, impaired language skills and personality changes.
Sunnybrook Health Sciences Centre is transforming health care through the dedication of its more than 10,000 staff, physicians and volunteers who provide compassionate and innovative patient focused care. An internationally recognized leader in academic research and education and an affiliation with the University of Toronto distinguishes Sunnybrook as one of Canada's premier health sciences centres. Sunnybrook specializes in caring for newborns, adults and the elderly, treating and preventing cancer, disorders of the brain, mind and nervous system, cardiovascular disease, orthopaedic and arthritic conditions and traumatic injuries.
-30-
*Please note: Dr. Herrmann can be made available for interviews on Wednesday, January 2nd.
/For further information: www.sunnybrook.ca/
Susan Berg, dementia expert, shares practical help for caregivers of those with dementia including easy to do activities
Wednesday, January 2, 2008
Saturday, December 29, 2007
Researchers Find Clue To Preventing Alzheimer's Disease
POSTED: 4:13 pm EST December 27, 2007
UPDATED: 4:32 pm EST December 27, 2007
Researchers may know why fish oil is helpful in preventing Alzheimer's disease.
Researchers at University of California, Los Angeles studied how a compound in fish oil, called Docosahexaenoic acid, or DHA, affects human brain cells and mice.
DHA appears to boost the production of a protein that destroys Alzheimer's-causing plaques.
DHA is found in fish oil supplements or fish like salmon.
Researchers are still trying to determine the most beneficial dose of DHA.
But, DHA may be most helpful for patients who haven't developed the disease yet.
UPDATED: 4:32 pm EST December 27, 2007
Researchers may know why fish oil is helpful in preventing Alzheimer's disease.
Researchers at University of California, Los Angeles studied how a compound in fish oil, called Docosahexaenoic acid, or DHA, affects human brain cells and mice.
DHA appears to boost the production of a protein that destroys Alzheimer's-causing plaques.
DHA is found in fish oil supplements or fish like salmon.
Researchers are still trying to determine the most beneficial dose of DHA.
But, DHA may be most helpful for patients who haven't developed the disease yet.
Tuesday, December 25, 2007
Regular Walking Protects the Aging Brain
Elders and all interested in maintaining their brain should exercise by Susan Berg author of Adorable Photographs of Our Baby-Meaningful Mind Stimulating Activities and More for the Memory Challenged, Their Loved Ones and Involved Professionals, and long time dementia care practitioner
Sunday, December 16, 2007
Grant to move UCR Alzheimer's study from mice to men
Download story podcast
10:00 PM PST on Friday, December 14, 2007
By ELAINE REGUS
The Press-Enterprise
A $2.1 million stem cell grant will allow a UC Riverside researcher to shift the focus of his Alzheimer's disease studies from mice to men.
Douglas Ethell, an assistant professor of biomedical sciences, said Friday that, until now, his research has focused on the rodent.
A study published last year showed that injecting specific T cells, which coordinate immune responses, from healthy mice into mice with Alzheimer's resulted in improved memory and learning.
click here for the whole story
10:00 PM PST on Friday, December 14, 2007
By ELAINE REGUS
The Press-Enterprise
A $2.1 million stem cell grant will allow a UC Riverside researcher to shift the focus of his Alzheimer's disease studies from mice to men.
Douglas Ethell, an assistant professor of biomedical sciences, said Friday that, until now, his research has focused on the rodent.
A study published last year showed that injecting specific T cells, which coordinate immune responses, from healthy mice into mice with Alzheimer's resulted in improved memory and learning.
click here for the whole story
Labels:
alzheimer's disease,
dementia,
dementiaviews
Monday, December 10, 2007
Study: Excessive Consumption of Sugary Drinks Linked Alzheimer's Disease
If you want to keep your mind sharp, you may want to lay off the soda. Excessive drinking of sugary beverages may increase the risk of Alzheimer's disease, according to a new study by the American Society for Biochemistry and Molecular Biology.
For the study, Dr. Ling Li, an assistant professor at the University of Alabama at Birmingham, and her colleagues tested whether high sugar consumption in an otherwise normal diet would affect Alzheimer’s progression.
Researchers used a genetic mouse model and over a 25-week period supplemented the regular
Click here for the whole story
For the study, Dr. Ling Li, an assistant professor at the University of Alabama at Birmingham, and her colleagues tested whether high sugar consumption in an otherwise normal diet would affect Alzheimer’s progression.
Researchers used a genetic mouse model and over a 25-week period supplemented the regular
Click here for the whole story
Sunday, December 9, 2007
Alzheimer's-as-diabetes debate
by The Star-Ledger Business Desk Friday December 07, 2007, 8:36 AM
Scientists have been searching for the cause of Alzheimer's disease for more than 100 years, and during that time, theories about why brain cells are destroyed in the course of the illness have come and gone. One of the newer and more unorthodox theories posits that Alzheimer's may actually be a form of diabetes, BusinessWeek reports. Some experts have even taken to calling the brain disease type 3 diabetes, as distinct from the insulin-dependent (type 1) and adult-onset (type 2) varieties of the condition.
The diabetes hypothesis stems from growing evidence that cells in the brains of Alzheimer's victims are resistant to insulin; just as in diabetes, the cells don't respond appropriately to this hormone. As a result, neurons are deprived of glucose, which they need for energy. As the evidence mounts, the type 3 label is gaining currency in Alzheimer's research circles and is drawing attention from the pharmaceutical industry. Pharma companies are testing existing diabetes drugs against Alzheimer's, while startup Acumen Pharmaceuticals, in partnership with Merck (MRK), is focusing on molecules that allow insulin to reach brain cells.
SUGAR-STARVED CELLS
If the fundamental understanding of Alzheimer's disease shifts in this direction, it could have a big impact on GlaxoSmithKline's (GSK) floundering diabetes drug, Avandia. Sales have dropped dramatically in recent months over concerns that the drug raises the risk of heart attack and bone disease in diabetics. But last year, a small clinical trial yielded intriguing evidence that Avandia might slow the progress of Alzheimer's. Glaxo is now testing the drug against a placebo on 3,400 Alzheimer's patients, with results expected in 2009
click here for the whole story
Scientists have been searching for the cause of Alzheimer's disease for more than 100 years, and during that time, theories about why brain cells are destroyed in the course of the illness have come and gone. One of the newer and more unorthodox theories posits that Alzheimer's may actually be a form of diabetes, BusinessWeek reports. Some experts have even taken to calling the brain disease type 3 diabetes, as distinct from the insulin-dependent (type 1) and adult-onset (type 2) varieties of the condition.
The diabetes hypothesis stems from growing evidence that cells in the brains of Alzheimer's victims are resistant to insulin; just as in diabetes, the cells don't respond appropriately to this hormone. As a result, neurons are deprived of glucose, which they need for energy. As the evidence mounts, the type 3 label is gaining currency in Alzheimer's research circles and is drawing attention from the pharmaceutical industry. Pharma companies are testing existing diabetes drugs against Alzheimer's, while startup Acumen Pharmaceuticals, in partnership with Merck (MRK), is focusing on molecules that allow insulin to reach brain cells.
SUGAR-STARVED CELLS
If the fundamental understanding of Alzheimer's disease shifts in this direction, it could have a big impact on GlaxoSmithKline's (GSK) floundering diabetes drug, Avandia. Sales have dropped dramatically in recent months over concerns that the drug raises the risk of heart attack and bone disease in diabetics. But last year, a small clinical trial yielded intriguing evidence that Avandia might slow the progress of Alzheimer's. Glaxo is now testing the drug against a placebo on 3,400 Alzheimer's patients, with results expected in 2009
click here for the whole story
Subscribe to:
Posts (Atom)

